GC Corp. (KRX:005250)
South Korea · Delayed Price · Currency is KRW 9,580.00
-170.00 (-1.74%)
At close: Oct 12, 2026
GC Corp. Market Cap
GC Corp. has a market cap or net worth of 435.33 billion as of October 12, 2026. It is the 17,721st most valuable company in the world and the 516th biggest in South Korea. Its market cap has decreased by 38.10% in one year.
Market Cap
435.33B
Enterprise Value
2.89T
Revenue
2.49T
Global Rank
Country Rank
#516 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since January 4, 1993, GC Corp.'s market cap has increased from 52.72B to 435.33B, an increase of 725.70%. That is a compound annual growth rate of 6.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 435.33B | -39.77% |
| Dec 30, 2025 | 722.80B | -8.08% |
| Dec 30, 2024 | 786.36B | 5.93% |
| Dec 28, 2023 | 742.32B | -3.82% |
| Dec 29, 2022 | 771.83B | -37.38% |
| Dec 30, 2021 | 1.23T | -34.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 724.29B |
| Onconic Therapeutics | 645.70B |
| Hyundai Bioscience | 611.83B |
| GI Innovation | 505.81B |
| AbClon | 490.82B |
| Proteina | 465.69B |
| Medy-Tox | 413.97B |
| Orum Therapeutics | 387.64B |